Power to Payers: Reimbursement Is the New Approval Paradigm
NEW YORK – Since payers have now replaced regulators as the Omega factor in the path to market success, the Holy Grail in drug development has transformed from regulatory approval to reimbursement – as evidenced by a trend in which some drugs have failed to live up to market expectations.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter